1. [Is paraoxonase 1 a marker of cardiovascular risk in youth with type 1 diabetes? (Study about 109 cases)]
- Author
-
Ons, Fekih, Sonia, Triki, Ilhem, Hellara, Fadoua, Neffati, Slaheddine, Chouchane, Mohamed, Neji Gueddiche, and Mohamed, Fadhel Najjar
- Subjects
Adult ,Glycated Hemoglobin ,Male ,Tunisia ,Adolescent ,Aryldialkylphosphatase ,Young Adult ,Diabetes Mellitus, Type 1 ,Cardiovascular Diseases ,Risk Factors ,Case-Control Studies ,Child, Preschool ,Humans ,Female ,Child ,Biomarkers ,Diabetic Angiopathies ,Retrospective Studies - Abstract
We purpose to verify if paraoxonase 1 (PON1) activity may be a marker of cardiovascular risk in a young Tunisian population with type 1 diabetes (T1D).PON1 activity was measured by a kinetic method using paraoxon as substrate. The other parameters were determined by automated methods.One hundred and nine children and adolescents with T1D and 97 healthy subjects were involved in this study. PON1 activity and PON1/HDL-cholesterol ratio were significantly decreased in diabetics (303 ± 174 vs. 372 ± 180 U/L and 221 ± 139 vs. 298 ± 20 1U/mmol, P=0.006, P=0.002, respectively) compared to controls. A significant increase in total cholesterol, LDL-c and microalbuminuria was observed in diabetics compared to controls. PON1 activity was decreased by 9.5% in patients with diabetes duration ≥ 6 years, by 28.4% for those with fasting glycemia ≥ 7 mmol/L (P0.001), by 14% in those with HbA1c ≥ 8% and by 12.3% for diabetics with dyslipidemia. PON1 activity is reduced when the number of cardiovascular risk factors increases (P0.001).PON1 seems to be associated to cardiovascular risk markers in T1D. This result remains to be seen. Nevertheless, improving PON1 activity could be a significant target for reducing cardiovascular risk.
- Published
- 2014